FDA, CMS unveil accelerated Medicare coverage pathway for breakthrough devices

The FDA and CMS jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway, a new accelerated Medicare coverage mechanism designed to synchronize FDA market authorization with CMS National Coverage Determinations. The initiative aims to reduce delays and streamline reimbursement access for breakthrough medical devices.